研究单位：[1]Takeda[2]Anhui Provincial Cancer Hospital,Hefei,Anhui,China,230031[3]Peking University Third Hospital,Beijing,Beijing,China,100010[4]The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China,361003[5]Union Hospital AffiliatedProf to Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China,430022[6]Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China,430030[7]Jiangsu Province Hospital/the Firstaffiliated Hospital Withnanjing Medical University,NanJing,Jiangsu,China,210000[8]The Firstaffiliated Hospital Ofsoochow University,SuZhou,Jiangsu,China,215000[9]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006[10]Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital),Shandong,Jinan,China,250000[11]The First Affiliated Hospital of China Medical University,ShenYang,Liaoning,China,110002[12]Shanghai Tongji Hospital,Shanghai,Shanghai,China,200065
The main aim is to see how adult participants with newly diagnosed or relapsed/refractory CD30+ lymphoma responded to any previous treatment in China. The study sponsor will not be involved in how participants are treated, the study only consists of collecting demographic and clinical records information from the hospital clinical systems. Based on the diagnosis of the disease, participants will be assigned to one of the following groups and their information will be analyzed within that group respectively: - Group A: Participants diagnosed with classical Hodgkin lymphoma (cHL). - Group B: participants diagnosed with non-Hodgkin lymphoma (NHL), including systemic anaplastic large-cell lymphoma [sALCL], peripheral T-cell lymphoma-not otherwise specified [PTCL-NOS], angioimmunoblastic T-cell lymphoma [AITL], extranodal NK/T-cell lymphoma [ENKTCL], mycosis fungoides [MF], primary cutaneous anaplastic large cell lymphoma [pcALCL], diffuse large B-cell lymphoma [DLBCL], primary mediastinal B-cell lymphoma [PMBCL]).
